Evaluating Guardant Health: Insights From 5 Financial Analysts
Evaluating Guardant Health: Insights From 5 Financial Analysts
評估監護人健康狀況：來自5位財務分析師的見解
In the preceding three months, 5 analysts have released ratings for Guardant Health (NASDAQ:GH), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師發佈了Guardant Health（納斯達克股票代碼：GH）的評級，提出了從看漲到看跌的各種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Guardant Health, presenting an average target of $32.0, a high estimate of $44.00, and a low estimate of $28.00. Experiencing a 17.95% decline, the current average is now lower than the previous average price target of $39.00.
在評估12個月目標股價時，分析師公佈了對Guardant Health的見解，平均目標股價爲32.0美元，最高估計爲44.00美元，低估值爲28.00美元。目前的平均價格下降了17.95％，現在低於之前的平均目標股價39.00美元。
Diving into Analyst Ratings: An...
深入分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。